Open in web browser

You are subscribed to the FormularyWatch eNews.

FormularyWatch

Share

eNews Subscribe

More Subscriptions

FORMULARY WATCH

HIV

Study: HIV PrEP drug may be 100% effective

By Tracey Walker
Pre-exposure prophylaxis (PrEP) may prevent HIV infection, according to a new study. It is one of the first and largest published evaluations of the use of PrEP to prevent HIV infection in a clinical practice setting. Here's what Kaiser Permanente researchers found

FDA approves Varubi for chemotherapy-induced nausea

By Erin Bastick
FDA has approved rolapitant (Varubi,Tesaro) for the prevention of chemotherapy-induced nausea and vomiting. More on this debilitating, but preventable condition

CONTINUING EDUCATION

MTM essentials for allergic rhinitis management
Session code: 15DT34-XVK37

This month's CE activity is part of the CPE series, "Medication Therapy Management for the Patient with Respiratory Disease." From April 2015 through December 2015, pharmacists can earn up to 18 hours of CPE credit with 9 monthly knowledge-based activities from the University of Connecticut School of Pharmacy and Drug Topics.

The goal of this month's activity is to discuss the pathophysiology and clinical presentation of allergic rhinitis and review nonpharmacologic and pharmacologic treatments for the symptoms of allergic rhinitis.

To read and print the article with TEST QUESTIONS, click here.

To proceed to the online exams and earn up to 2 CPE credits, click here to log in with the session code 15DT34-XVK37.

Copy the session code — 15DT34-XVK37 — before logging into the Online CE Center. When the page for the Online CE Center opens, paste the session code into the appropriate field, under your NABP ID.

EDITOR'S PICK

[BLOG]: Sepsis: 4 things formulary managers can do to save lives, resources

By Mike Abrams
It's Sepsis Awareness Month. What you can do: Advice from the president and CEO of the Ohio Hospital Association. Read more

September 11, 2015

Related Articles

HIV/AIDS drugs reclassified at Aetna, Coventry in Florida

Continued advances in cancer outcomes unveiled at ASCO

Resources

Get the latest FormularyWatch updates on drug approvals, current studies, and other findings.

Click for the latest Clinical News

Click here to contact Editorial. Sales, Reprints, Classified questions? Click here to contact the Sales Team.

ModernMedicine logo
UBM  logo

UBM MEDICA